Skip to main content
. 2024 Aug 3;16(8):e66088. doi: 10.7759/cureus.66088

Table 5. Association between biomarker expression and clinical outcomes.

p53: Tumor protein p53; EGFR: estimated glomerular filtration rate; CK20: cytokeratin 20

Biomarker Treatment Response Recurrence
p53
-Positive 84 (70.0) 22 (18.3)
-Negative 48 (88.9) 6 (11.1)
Ki-67
-High expression 72 (66.7) 24 (22.2)
-Low expression 60 (90.9) 4 (6.1)
EGFR
-Overexpression 60 (62.5) 20 (20.8)
-Normal expression 72 (92.3) 8 (10.3)
CK20
-Positive 96 (75.0) 24 (18.8)
-Negative 36 (85.7) 4 (9.5)